光線力学療法の世界市場：製品タイプ別、光源別、用途別、エンドユーザー別、地域範囲別、予測

光線力学療法の市場規模と予測

光線力学療法の市場規模は、2024年に48億1,000万米ドルと評価され、2026～2032年にかけてCAGR 6.10%で成長し、2032年には74億米ドルに達すると予測されています。

光線力学療法（PDT）は、光増感剤として知られる光に反応する医薬品を使用して、異常細胞や悪性細胞を標的にして破壊する医療処置です。この療法法では、標的細胞に蓄積する光増感剤を投与します。特定の波長の光を照射すると、光増感剤が反応して酸素を発生させ、標的細胞を死滅させています。

光線力学療法（PDT）は、光増感剤と呼ばれる光に反応する医薬品と特定の波長の光を用いて、異常細胞や悪性細胞を標的にして破壊する療法法です。光を照射すると光増感剤が反応し、一種の酸素を放出して標的細胞に害を与えます。PDTは、特定のがん、皮膚疾患、眼疾患の療法によく用いられます。

光線力学療法は、がんや皮膚疾患の療法だけでなく、より多くの方法で使われるようになると考えられます。PDTの進歩により、より広範な悪性腫瘍、特に到達しにくい部位の悪性腫瘍の療法において、その有効性が高まると予測されます。細菌やウイルス感染などの感染症療法に対するPDTの可能性も、再生医療への応用と同様に研究されています。

光線力学療法の世界市場力学

世界の光線力学療法市場を形成している主要市場力学は以下の通りです。

主要市場促進要因

技術の進歩：技術進歩はPDT市場の重要な促進要因です。光増感剤の開発、光照射方法、イメージング技術の進歩により、光線力学療法の有効性と安全性が大幅に向上しました。より特異性が高く副作用の少ない新しい光増感剤が開発され、がん細胞やその他の疾患組織をより正確にターゲティングできるようになっています。レーザーやLEDのような光源の改善や画像技術の向上により、療法のモニタリングやコントロールが向上し、最終的に療法成績が改善されます。

がんやその他の疾患の有病率の増加：がんやその他の慢性疾患の頻度増加は、PDT市場の主要促進要因です。がん罹患率が世界的に上昇するにつれて、より優れた療法オプションに対する要望が高まっています。PDTは、標準的な療法よりも副作用の可能性が低く、がん療法において魅力的な選択肢です。

認識と受容の高まり：医療従事者や患者におけるPDTの知識と受容の高まりは、市場成長の重要な促進要因です。PDTの有効性と安全性に関する科学的根拠が高まるにつれて、療法戦略にPDTを採用する医療従事者が増えています。また、低侵襲性や回復時間の短縮といったPDTの利点に関する患者の知識も広がっています。

主要課題

高額な費用とアクセシビリティ：最も大きな問題の一つは、PDT療法と関連機器の高額な費用です。光増感剤や特殊な光照射システムの研究や製造には多額の費用がかかり、その結果、患者には多額の療法費がかかることになります。この高コストが、特に貧しい国や十分な保険が適用されない患者にとって、利用しやすさを制限している可能性があります。

限られた臨床応用と有効性：PDTは特定の悪性腫瘍や皮膚疾患の療法において有望視されているが、その実用的な用途は依然として限られています。PDTの有効性は疾患タイプや病期、使用する光増感剤、照射方法によって異なります。深在性腫瘍や光の透過性が低い複雑な状況に対するPDTの最適化には、さらなるハードルがあります。

規制と承認のハードル：新しい療法法や技術の承認に関する要件は国によって異なるため、PDTの規制状況をナビゲートすることは困難です。長くて困難な規制手続きは、革新的なPDT商品や療法法の導入を遅らせる原因となります。さらに、規制当局の許可を得るには、大規模な臨床検査やPDTの安全性と有効性の証明が必要となることが多く、時間と費用がかかります。

主要動向

技術の進歩：技術の進歩は光線力学療法市場に大きな影響を与えています。PDTに不可欠な光増感剤の進歩は、療法効果を向上させ、副作用を低下させています。さらに、レーザーやLED技術などの光送達システムの進歩により、光の浸透の精度と深さが増し、さまざまな腫瘍や病変に対するPDTの効果が高まっています。

療法応用の拡大：PDTで療法される疾患の範囲は拡大しており、これが市場の成長に寄与しています。PDTは従来、がんや皮膚科疾患に使用されてきたが、加齢黄斑変性やその他の眼疾患を療法するために眼科でも使用されるようになっています。

併用療法への注目の高まり：全体的な療法効果を高めるために、光線力学療法と他の療法法を併用する傾向が高まっています。PDTは化学療法、放射線療法、免疫療法と併用することで、有効性を向上させ、抵抗性を減らし、腫瘍をより的確に捉えることが研究されています。これらの併用アプローチは、単独で使用した場合のPDTの限界を克服することを目的としており、その結果、臨床診療におけるPDTの採用と適用性が高まっています。

光線力学療法市場の地域別分析

世界の光線力学療法市場について、より詳細な地域分析を発表します。

北米

北米が光線力学療法（PDT）市場を独占しているのは、先進的ヘルスケアインフラ、研究開発への多額の投資、画期的な医療技術の広範な受容など、多くの主要因によるものです。特に米国では、数多くの重要な製薬企業やバイオテクノロジー企業がPDTの技術革新を推進しています。これらの企業は、重要な臨床検査やPDT新製品の開発に携わっており、PDT技術の進歩や商業化に貢献しています。

さらに、北米の強固な規制の枠組みは、新規PDT療法の開発と承認を促進しています。米国食品医薬品局（FDA）をはじめとする北米の規制当局は、PDT療法が高い安全性と有効性の基準を満たすことを保証し、承認と商業化のための強力な枠組みを提供しています。このような規制当局の支援は、ヘルスケアインフラや調査への大規模な投資と相まって、この地域におけるPDTの拡大と優位性を支える雰囲気を作り出しています。

アジア太平洋

アジア太平洋は、光線力学療法（PDT）産業において最も急成長している地域です。中国、インド、日本などの国々における急速な経済拡大とヘルスケア支出の増加が市場成長を後押ししています。同地域では、ヘルスケアのインフラが整備され、PDTのような新しい療法法の導入が容易になる技術の向上が見られます。さらに、がんや皮膚疾患などの慢性疾患の有病率が上昇していることも、新たな療法法の必要性を高めています。

さらに、アジア太平洋市場には膨大かつ多様な患者層が存在するため、PDTの採用に大きな展望が立っています。同地域では、PDTの用途拡大や療法成績の向上を目的とした臨床検査や研究プロジェクトも増加しています。ヘルスケア関係者や患者がPDTの利点やさまざまな疾患の療法の可能性を認識するようになるにつれ、市場は急速に拡大するとみられます。

目次

第1章 世界の光線力学療法市場の導入

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 光線力学療法の世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 光線力学療法の世界市場：製品別

• 概要
• 光線力学療法機器
• 光増感剤

第6章 光線力学療法の世界市場：光源別

• 概要
• レーザー
• 発光ダイオード（LED）
• ランプ
• その他

第7章 光線力学療法の世界市場：用途別

• 概要
• がん
• 光線力学療法
• にきび
• 乾癬
• その他

第8章 光線力学療法の世界市場：エンドユーザー別

• 概要
• 病院
• 美容・皮膚科クリニック
• がん療法センター
• その他

第9章 光線力学療法の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋
• その他
  • 中東・アフリカ
  • 南米

第10章 世界の光線力学療法市場の競合情勢

• 概要
• 各社の市場ランキング
• 主要開発戦略

第11章 企業プロファイル

• Sun Pharmaceutical Industries Ltd.
• Galderma Laboratories L.P.
• Biofrontera AG
• LUMIBIRD
• Bausch Health
• Theralase Technologies Inc.
• Modulight, Inc.
• Hologic, Inc.
• Quest PharmaTech Inc.
• SUS Advancing Technology Co., Ltd.

第12章 主要開発

• 製品の上市/開発
• 合併と買収
• 事業拡大
• パートナーシップと提携

第13章 付録

• 関連調査

Photodynamic Therapy Market Size And Forecast

Photodynamic Therapy Market size was valued at USD 4.81 Billion in 2024 and is projected to reach USD 7.4 Billion by 2032, growing at a CAGR of 6.10% from 2026 to 2032.

Photodynamic therapy (PDT) is a medical procedure that employs light-sensitive medicines known as photosensitizers to target and destroy aberrant or malignant cells. The therapy entails delivering a photosensitizer which accumulates in target cells. When exposed to a specific wavelength of light, the photosensitizer reacts and produces a type of oxygen that kills the target cells.

Photodynamic therapy (PDT) is a medical treatment that employs light-sensitive medicines known as photosensitizers and a specific wavelength of light to target and destroy aberrant or malignant cells. When exposed to light, the photosensitizer reacts and emits a type of oxygen that harms the target cells. PDT is commonly used to treat certain cancers, skin problems, and eye disorders.

Photodynamic treatment (PDT) will be used in more ways than just treating cancer and dermatological diseases. Advances in PDT are projected to increase its efficacy in treating a broader range of malignancies, particularly those in hard-to-reach regions. PDT's potential for treating infectious disorders such as bacterial and viral infections is also being investigated as is its application in regenerative medicine.

Global Photodynamic Therapy Market Dynamics

The key market dynamics that are shaping the global photodynamic therapy market include:

Key Market Drivers:

Technological Advancements: Technological advancements are a significant driver of the PDT market. Advances in photosensitizer creation, light delivery methods, and imaging techniques have considerably enhanced the effectiveness and safety of photodynamic therapy. Newer photosensitizers with increased specificity and fewer side effects are being developed enabling more precise targeting of cancer cells and other diseased tissues. Improvements in light sources such as lasers and LEDs as well as the incorporation of improved imaging techniques allow for better therapy monitoring and control, ultimately improving treatment outcomes.

Increasing Prevalence of Cancer and Other Diseases: The increased frequency of cancer and other chronic diseases is a major driver of the PDT market. As cancer rates rise worldwide, there is an increased desire for better therapeutic options. PDT provides a minimally intrusive technique with the potential for fewer adverse effects than standard therapies making it an appealing choice for cancer treatment.

Growing Awareness and Acceptance: Increased knowledge and acceptance of PDT among healthcare professionals and patients are critical market growth drivers. As scientific evidence for the efficacy and safety of PDT grows, more healthcare practitioners are adopting it into their treatment strategies. Patient knowledge of the advantages of PDT such as its minimally invasive nature and shorter recovery times is also growing.

Key Challenges:

High Costs and Accessibility: One of the most significant issues is the high cost of PDT treatments and related equipment. The research and manufacturing of photosensitizers and specialized light delivery systems can be costly resulting in significant treatment expenses for patients. This high cost may limit accessibility, particularly in poorer countries or for patients without adequate insurance coverage.

Limited Clinical Applications and Efficacy: PDT has shown promise in the treatment of certain malignancies and dermatological diseases but its practical uses remain limited. PDT's effectiveness varies according to the type and stage of the disease, the photosensitizer utilized, and the manner of delivery. Optimizing PDT for deep-seated tumors or complex circumstances with low light penetration presents additional hurdles.

Regulatory and Approval Hurdles: Navigating the regulatory landscape for PDT can be difficult because different nations have varied requirements for the approval of new therapies and technology. The lengthy and difficult regulatory procedure can cause delays in the introduction of innovative PDT goods and therapies. Furthermore, obtaining regulatory permission frequently necessitates significant clinical trials and proof confirming the safety and efficacy of PDT which can be time-consuming and expensive.

Key Trends:

Advancements in Technology: Technological advancements are greatly influencing the photodynamic therapy market. Photosensitizer advancements which are critical for PDT are improving therapy efficacy and lowering adverse effects. Furthermore, advances in light delivery systems such as laser and LED technologies are increasing the precision and depth of light penetration making PDT more effective for a variety of tumors and lesions.

Expanding Therapeutic Applications: The range of disorders treated with PDT is expanding which contributes to market growth. While PDT has traditionally been used for cancer and dermatological illnesses it is also being used in ophthalmology to treat age-related macular degeneration and other eye disorders.

Increasing Focus on Combination Therapies: There is a growing trend of combining photodynamic therapy with other treatment modalities to improve overall therapeutic results. PDT is being studied in combination with chemotherapy, radiation, and immunotherapy to improve efficacy, reduce resistance, and better target tumors. These combined approaches aim to overcome PDT's limitations when used alone, hence increasing its adoption and applicability in clinical practice.

Photodynamic Therapy Market Regional Analysis

Here is a more detailed regional analysis of the global photodynamic therapy market:

North America:

North America dominates the photodynamic treatment (PDT) market due to many major factors including advanced healthcare infrastructure, significant investment in R&D, and widespread acceptance of breakthrough medical technologies. Numerous significant pharmaceutical and biotechnology organizations, particularly in the United States, drive PDT innovation. These firms are involved in significant clinical trials and the development of new PDT products which help to advance and commercialize PDT technologies.

Furthermore, North America's robust regulatory framework promotes the development and approval of novel PDT therapies. The United States Food and Drug Administration (FDA) and other North American regulatory authorities provide a strong framework for approving and commercializing PDT treatments ensuring that they fulfill high safety and efficacy criteria. This regulatory support, combined with large investments in healthcare infrastructure and research creates an atmosphere that supports PDT's expansion and supremacy in the region.

Asia Pacific:

Asia Pacific is the fastest-growing area in the photodynamic treatment (PDT) industry owing to several factors. Rapid economic expansion and increased healthcare spending in nations such as China, India, and Japan are propelling market growth. The region is seeing an increase in healthcare infrastructure and technology improvements making it easier to embrace novel therapies such as PDT. Furthermore, the rising prevalence of chronic diseases such as cancer and dermatological problems drives the need for new treatment alternatives.

Furthermore, the Asia Pacific market has a vast and diversified patient population, providing great prospects for PDT adoption. The region is also seeing an increase in clinical trials and research projects aimed at broadening PDT uses and enhancing treatment outcomes. As healthcare practitioners and patients become more aware of PDT's benefits and potential to treat a variety of medical ailments, the market is likely to expand rapidly.

Global Photodynamic Therapy Market: Segmentation Analysis

The Global Photodynamic Therapy Market is segmented based on Product Type, Light Source, End-User, Application, and Geography.

Photodynamic Therapy Market, By Product Type

• Photosensitizer Drugs
• Photodynamic Therapy Devices

Based on the Product Type, the Photodynamic Therapy Market is bifurcated into Photosensitizer Drugs and photodynamic Therapy Devices. Photosensitizer drugs are more dominant in the photodynamic therapy (PDT) market. They are crucial for the effectiveness of PDT, as they are the compounds activated by light to produce a therapeutic effect. The development and commercialization of new photosensitizers drive market growth by expanding treatment options and improving efficacy and safety.

Photodynamic Therapy Market, By Light Source

• Lasers
• Light Emitting Diodes (LEDs)
• Lamps
• Others

Based on the Light Source, the Photodynamic Therapy Market is bifurcated into Lasers, Light Emitting Diodes (LEDs), Lamps, and others. Lasers are the most dominant technology in the photodynamic therapy (PDT) market. They provide precise, controlled light delivery, essential for targeting specific areas with accuracy. Lasers offer superior depth penetration and intensity modulation which is critical for effective PDT treatment, especially in oncology and dermatology. Their ability to focus light precisely on the affected area enhances treatment efficacy and minimizes damage to surrounding healthy tissue.

Photodynamic Therapy Market, By End-User

• Hospitals
• Cancer Treatment Centers
• Cosmetic and Dermatology Clinics
• Others

Based on the End-User, the Photodynamic Therapy Market is bifurcated into Hospitals, Cancer Treatment Centers, Cosmetic & Dermatology Clinics, and others. Cancer treatment centers are the most dominant in the Photodynamic Therapy (PDT) Market. These centers are key players due to the high prevalence of cancers that PDT effectively targets such as skin and certain head and neck cancers. PDT's role in providing localized treatment with minimal invasiveness aligns well with the specialized needs of cancer treatment centers. The center's focus on advanced and comprehensive cancer therapies drives significant demand for PDT supporting its growth and integration into its therapeutic offerings.

Photodynamic Therapy Market, By Application

• Cancer
• Actinic Keratosis (AK)
• Psoriasis
• Acne
• Others

Based on the Application, the Photodynamic Therapy Market is bifurcated into Cancer, Actinic Keratosis (AK), Psoriasis, Acne, and others. Cancer is the most dominant application in the photodynamic therapy (PDT) market. This dominance stems from PDT's effectiveness in treating various types of cancers including skin, lung, and esophageal cancers. The ability of PDT to selectively target and destroy cancer cells with minimal damage to surrounding tissues makes it a valuable treatment option. Additionally, ongoing research and clinical trials continue to expand PDT's applications in oncology driving significant investment and interest in this area.

Photodynamic Therapy Market, By Geography

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Rest of the world

Based on Geography, the Photodynamic Therapy Market is classified into North America, Europe, Asia Pacific, Middle East and Africa, and the Rest of the world. North America is the most dominant region in the photodynamic therapy market. This dominance is attributed to its advanced healthcare infrastructure, high level of research and development, and strong presence of leading medical technology companies. The region benefits from substantial investments in innovative treatments and has a high adoption rate of new therapies due to its well-established healthcare systems. Additionally, North America's significant clinical trial activity and regulatory support for new PDT technologies contribute to its leadership in the market.

Key Players

• The "Photodynamic Therapy Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Theralase Technologies Inc., Biofrontera AG, Hologic, Inc., Bausch Health, Quest PharmaTech Inc., LUMIBIRD, Galderma Laboratories L.P., Modulight, Inc., Sun Pharmaceutical Industries Ltd., and SUS Advancing Technology Co., Ltd.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Photodynamic Therapy Market Key Developments

• In January 2023, Biofrontera AG, an international biopharmaceutical company, announced that its wholly-owned subsidiary Biofrontera Bioscience GmbH received a notice of allowance from the USPTO for the application "Photodynamic therapy comprising two light exposures at different wavelengths".
• In October 2022, Professor Xiuli Wang, Shanghai Skin Disease Hospital, Tongji University School of Medicine (China), has been selected as the recipient of the 2022 Clinical PDT Research Excellence Award, by the International Photodynamic Association (IPA). The Clinical PDT Research Excellence Award honors Professor Wang's substantial career achievements, which significantly accelerated the uptake of photodynamic treatment in China.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL PHOTODYNAMIC THERAPY MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL PHOTODYNAMIC THERAPY MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL PHOTODYNAMIC THERAPY MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Photodynamic Therapy Devices
• 5.3 Photosensitizer Drug

6 Photodynamic Therapy Market, By Light Source

• 6.1 Overview
• 6.2 Lasers
• 6.3 Light Emitting Diodes (LEDs)
• 6.4 Lamps
• 6.5 Others

7 GLOBAL PHOTODYNAMIC THERAPY MARKET, BY APPLICATION

• 7.1 Overview
• 7.2 Cancer
• 7.3 Actinic Keratosis
• 7.4 Acne
• 7.5 Psoriasis
• 7.7 Others

8 GLOBAL PHOTODYNAMIC THERAPY MARKET, BY END-USER

• 8.1 Overview
• 8.2 Hospital
• 8.3 Cosmetic and Dermatology Clinics
• 8.4 Cancer Treatment Centers
• 8.5 Others

9 GLOBAL PHOTODYNAMIC THERAPY MARKET, BY GEOGRAPHY

• 9.1 Overview
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 U.K.
  • 9.3.3 France
  • 9.3.4 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Rest of Asia Pacific
• 9.5 Rest of the World
  • 9.5.1 Middle East and Africa
  • 9.5.2 South America

10 GLOBAL PHOTODYNAMIC THERAPY MARKET COMPETITIVE LANDSCAPE

• 10.1 Overview
• 10.2 Company Market Ranking
• 10.3 Key Development Strategies

11 COMPANY PROFILES

• 11.1 Sun Pharmaceutical Industries Ltd.
  • 11.1.1 Overview
  • 11.1.2 Financial Performance
  • 11.1.3 Product Outlook
  • 11.1.4 Key Developments
• 11.2 Galderma Laboratories L.P.
  • 11.2.1 Overview
  • 11.2.2 Financial Performance
  • 11.2.3 Product Outlook
  • 11.2.4 Key Developments
• 11.3 Biofrontera AG
  • 11.3.1 Overview
  • 11.3.2 Financial Performance
  • 11.3.3 Product Outlook
  • 11.3.4 Key Developments
• 11.4 LUMIBIRD
  • 11.4.1 Overview
  • 11.4.2 Financial Performance
  • 11.4.3 Product Outlook
  • 11.4.4 Key Developments
• 11.5 Bausch Health
  • 11.5.1 Overview
  • 11.5.2 Financial Performance
  • 11.5.3 Product Outlook
  • 11.5.4 Key Developments
• 11.6 Theralase Technologies Inc.
  • 11.6.1 Overview
  • 11.6.2 Financial Performance
  • 11.6.3 Product Outlook
  • 11.6.4 Key Developments
• 11.7 Modulight, Inc.
  • 11.7.1 Overview
  • 11.7.2 Financial Performance
  • 11.7.3 Product Outlook
  • 11.7.4 Key Developments
• 11.8 Hologic, Inc.
  • 11.8.1 Overview
  • 11.8.2 Financial Performance
  • 11.8.3 Product Outlook
  • 11.8.4 Key Developments
• 11.9 Quest PharmaTech Inc.
  • 11.9.1 Overview
  • 11.9.2 Financial Performance
  • 11.9.3 Product Outlook
  • 11.9.4 Key Developments
• 11.11 SUS Advancing Technology Co., Ltd.
  • 11.11.1 Overview
  • 11.11.2 Financial Performance
  • 11.11.3 Product Outlook
  • 11.11.4 Key Developments

12 KEY DEVELOPMENTS

• 12.1 Product Launches/Developments
• 12.2 Mergers and Acquisitions
• 12.3 Business Expansions
• 12.4 Partnerships and Collaborations

13 Appendix

• 13.1.1 Related Research